Found: 2
Select item for more details and to access through your institution.
Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 1, p. 1, doi. 10.1002/ctm2.704
- By:
- Publication type:
- Article
Clinical and Microbiological Impact of Implementing a Decision Support Algorithm through Microbiologic Rapid Diagnosis in Critically Ill Patients: An Epidemiological Retrospective Pre-/Post-Intervention Study.
- Published in:
- Biomedicines, 2023, v. 11, n. 12, p. 3330, doi. 10.3390/biomedicines11123330
- By:
- Publication type:
- Article